Literature DB >> 26342170

Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review.

J R W Brownrigg1, R J Hinchliffe1, J Apelqvist2, E J Boyko3, R Fitridge4, J L Mills5, J Reekers6, C P Shearman7, R E Zierler8, N C Schaper9.   

Abstract

Non-invasive tests for the detection of peripheral artery disease (PAD) among individuals with diabetes mellitus are important to estimate the risk of amputation, ulceration, wound healing and the presence of cardiovascular disease, yet there are no consensus recommendations to support a particular diagnostic modality over another and to evaluate the performance of index non-invasive diagnostic tests against reference standard imaging techniques (magnetic resonance angiography, computed tomography angiography, digital subtraction angiography and colour duplex ultrasound) for the detection of PAD among patients with diabetes. Two reviewers independently screened potential studies for inclusion and extracted study data. Eligible studies evaluated an index test for PAD against a reference test. An assessment of methodological quality was performed using the quality assessment for diagnostic accuracy studies instrument. Of the 6629 studies identified, ten met the criteria for inclusion. In these studies, the patients had a median age of 60-74 years and a median duration of diabetes of 9-24 years. Two studies reported exclusively on patients with symptomatic (ulcerated/infected) feet, two on patients with asymptomatic (intact) feet only, and the remaining six on patients both with and without foot ulceration. Ankle brachial index (ABI) was the most widely assessed index test. Overall, the positive likelihood ratio and negative likelihood ratio (NLR) of an ABI threshold <0.9 ranged from 2 to 25 (median 8) and <0.1 to 0.7 (median 0.3), respectively. In patients with neuropathy, the NLR of the ABI was generally higher (two out of three studies), indicating poorer performance, and ranged between 0.3 and 0.5. A toe brachial index <0.75 was associated with a median positive likelihood ratio and NLRs of 3 and ≤ 0.1, respectively, and was less affected by neuropathy in one study. Also, in two separate studies, pulse oximetry used to measure the oxygen saturation of peripheral blood and Doppler wave form analyses had NLRs of 0.2 and <0.1. The reported performance of ABI for the diagnosis of PAD in patients with diabetes mellitus is variable and is adversely affected by the presence of neuropathy. Limited evidence suggests that toe brachial index, pulse oximetry and wave form analysis may be superior to ABI for diagnosing PAD in patients with neuropathy with and without foot ulcers. There were insufficient data to support the adoption of one particular diagnostic modality over another and no comparisons existed with clinical examination. The quality of studies evaluating diagnostic techniques for the detection of PAD in individuals with diabetes is poor. Improved compliance with guidelines for methodological quality is needed in future studies.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  diabetes; diagnosis; investigations; peripheral artery disease

Mesh:

Year:  2016        PMID: 26342170     DOI: 10.1002/dmrr.2703

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  14 in total

1.  Non-invasive vascular screening test to diagnose peripheral vascular disease.

Authors:  Lawrence A Lavery; Peter Andrew Crisologo
Journal:  Ann Transl Med       Date:  2018-12

2.  A Critical Evaluation of Existing Diabetic Foot Screening Guidelines.

Authors:  Cynthia Formosa; Alfred Gatt; Nachiappan Chockalingam
Journal:  Rev Diabet Stud       Date:  2016-08-10

3.  Effect of tibial cortex transverse transport in patients with recalcitrant diabetic foot ulcers: A prospective multicenter cohort study.

Authors:  Yan Chen; Xiaofang Ding; Yueliang Zhu; Zhongwei Jia; Yong Qi; Mingyong Chen; Jili Lu; Xiaocong Kuang; Jia Zhou; Yongfeng Su; Yongxin Zhao; William Lu; Jinmin Zhao; Qikai Hua
Journal:  J Orthop Translat       Date:  2022-10-12       Impact factor: 4.889

4.  Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes.

Authors:  Julian F Guest; Graham W Fuller; Peter Vowden
Journal:  Int Wound J       Date:  2017-12-15       Impact factor: 3.315

5.  Outcomes and prognosis of diabetic foot ulcers treated by an interdisciplinary team in Canada.

Authors:  Jérôme Patry; André Tourigny; Marie-Philippe Mercier; Clermont E Dionne
Journal:  Int Wound J       Date:  2020-11-25       Impact factor: 3.315

6.  Automated oscillometric blood pressure and pulse-wave acquisition for evaluation of vascular stiffness in atherosclerosis.

Authors:  Alexander Massmann; Jennifer Stemler; Peter Fries; Reinhard Kubale; Lutz Erwin Kraushaar; Arno Buecker
Journal:  Clin Res Cardiol       Date:  2017-02-06       Impact factor: 5.460

7.  Proximal Tibial Cortex Transverse Distraction Facilitating Healing and Limb Salvage in Severe and Recalcitrant Diabetic Foot Ulcers.

Authors:  Yan Chen; Xiaocong Kuang; Jia Zhou; Puxiang Zhen; Zisan Zeng; Zhenxun Lin; Wei Gao; Lihuan He; Yi Ding; Guangwei Liu; Shaohua Qiu; An Qin; William Lu; Shan Lao; Jinmin Zhao; Qikai Hua
Journal:  Clin Orthop Relat Res       Date:  2020-04       Impact factor: 4.755

8.  Dressings and topical agents for arterial leg ulcers.

Authors:  Cathryn Broderick; Fania Pagnamenta; Rachel Forster
Journal:  Cochrane Database Syst Rev       Date:  2020-01-20

9.  Management of peripheral arterial disease in diabetes: a national survey of podiatry practice in the United Kingdom.

Authors:  Pasha Normahani; Chira Mustafa; Nigel J Standfield; Claire Duguid; Martin Fox; Usman Jaffer
Journal:  J Foot Ankle Res       Date:  2018-06-08       Impact factor: 2.303

10.  Comparison of a new versus standard removable offloading device in patients with neuropathic diabetic foot ulcers: a French national, multicentre, open-label randomized, controlled trial.

Authors:  Louis Potier; Maud François; Dured Dardari; Marilyne Feron; Narimene Belhatem; Estelle Nobecourt-Dupuy; Manuel Dolz; Lyse Bordier; Roxane Ducloux; Abdelkader Chibani; Dominique-François Eveno; Teresa Crea Avila; Ariane Sultan; Laurence Baillet-Blanco; Vincent Rigalleau; Elise Gand; Pierre-Jean Saulnier; Gilberto Velho; Ronan Roussel; Quentin Pellenc; Jean-Claude Dupré; Dominique Malgrange; Michel Marre; Kamel Mohammedi
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.